-
1 Comment
Shanghai Hile Bio-Technology Co., Ltd is currently in a long term downtrend where the price is trading 5.4% below its 200 day moving average.
From a valuation standpoint, the stock is 328.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 41.3.
Shanghai Hile Bio-Technology Co., Ltd's total revenue sank by 1.2% to $77M since the same quarter in the previous year.
Its net income has dropped by 35.0% to $5M since the same quarter in the previous year.
Finally, its free cash flow fell by 105.8% to $-6M since the same quarter in the previous year.
Based on the above factors, Shanghai Hile Bio-Technology Co., Ltd gets an overall score of 0/5.
| ISIN | CNE1000022T4 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | SHG |
| CurrencyCode | CNY |
| Beta | 0.51 |
|---|---|
| Market Cap | 3B |
| PE Ratio | 20.38 |
| Target Price | 15 |
| Dividend Yield | 1.5% |
Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloproteinase 3, IV collagen, adiponectin, creatine kinase isoenzyme, hepatic bile acid, cardiac troponin I, heparin binding protein, hemoglobin A1C, lipoprotein phospholipase A2, heart fatty acid binding protein, ferritin, sialoglycoside antigen, and procalcitonin kits. The Oral Tissue Repair and Regeneration Materials segment provides oral bone repair materials, implant systems, natural bone repair materials, oral restorative films, collagen-based bone repair matrices, and soft tissue repair matrices, primarily for dental implantation and maxillofacial bone defect repair. The company was founded in 1981 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603718.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
